← back to search

Tsuyoshi Takahashi

Osaka Gakuin University · JP
Area of research
Surgery · Gastroenterology
Research interest
Research interests include Gastrointestinal Tumor Research and Treatment, Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment, and Esophageal and GI Pathology.
h-index
56
citations
13,814
works
741
NIH funding
primary concept
Medicine
email

Recent publications

Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy.
2026cited by 1position: contributordoi
Clinical significance of comprehensive genomic profiling in unresectable or recurrent gastrointestinal stromal tumors: a multicenter retrospective cohort study.
2026cited by 0position: contributordoi
Correction: APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation.
2026cited by 0position: contributordoi
Prognostic Impact of Immunoscore in Pathological Stage III Differentiated Gastric Cancer: A Multicenter Cohort Study Including PD-L1/PD-L2 Expression Analysis.
2026cited by 0position: contributordoi
PD-1 antibody-bound progenitor-exhausted CD8<sup>+</sup> T cells in lymph nodes boost PD-1-blockade anti-tumor immunity in gastrointestinal cancer.
2026cited by 0position: contributordoi
y-shaped side overlap esophagogastrostomy in proximal gastrectomy.
2025cited by 2position: contributordoi
Clinical impact of primary and secondary KIT mutations on the efficacy of molecular-targeted therapies in gastrointestinal stromal tumors.
2025cited by 1position: contributordoi
Targeting yes-associated protein to overcome imatinib resistance in gastrointestinal stromal tumor drug-tolerant persister cells.
2025cited by 0position: contributordoi
Long-Term Survival Following Multimodal Therapy with Sunitinib and Surgery for Recurrent Duodenal Gastrointestinal Stromal Tumor.
2025cited by 0position: contributordoi
High expression of the cachexia-related protein Fn14 in esophageal squamous cell carcinoma correlates with poor chemotherapy response and anti-Fn14 therapy decreases chemotherapeutic resistance.
2025cited by 0position: contributordoi
Significance of Neoadjuvant S-1-Based Chemotherapy for Older Patients With Locally Advanced Gastric Cancer.
2025cited by 0position: contributordoi
<i>Helicobacter pylori</i> prevalence and its spontaneous eradication rate after distal or proximal gastrectomy for gastric cancer: A multicenter prospective cohort study.
2025cited by 0position: contributordoi
Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors.
2024cited by 14position: contributordoi
Lipolysis-stimulated lipoprotein receptor promote lipid uptake and fatty acid oxidation in gastric cancer.
2024cited by 7position: contributordoi
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.
2024cited by 7position: contributordoi
The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry.
2024cited by 4position: contributordoi
Laparoscopically assisted diaphragmatic hernia repair with mesh and a myocutaneous flap after left ventricular assist device explantation: A case report.
2024cited by 1position: contributordoi
PD-1 antibody–bound progenitor-exhausted CD8+ T cells in lymph nodes boost PD-1–blockade anti-tumor immunity in gastrointestinal cancer
2024cited by 0position: contributordoi
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors.
2023cited by 72position: contributordoi
Combination of pimitespib (TAS-116) with sunitinib is an effective therapy for imatinib-resistant gastrointestinal stromal tumors.
2023cited by 18position: contributordoi
Long-term survival and prognostic factors associated with curative conversion surgery for ct4b esophageal squamous cell carcinoma: Analysis of 200 consecutive cases
Surgery 2023cited by 13position: contributordoi
Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST.
2023cited by 10position: contributordoi
Risk stratification of oesophageal squamous cell carcinoma using change in total lesion glycolysis and number of PET-positive lymph nodes.
2023cited by 10position: contributordoi
Long-term response to pimitespib in postoperative recurrent gastrointestinal stromal tumors with PDGFRA D842V mutation: a case report.
2023cited by 3position: contributordoi
Laparoscopic repair of a traumatic diaphragmatic hernia with repeated colon incarcerations 7 years after injury: a case report.
2023cited by 1position: contributordoi
Laparoscopic resection for recurrent gastrointestinal stromal tumors and paraganglioma in a patient with Carney-Stratakis syndrome: A case report.
2023cited by 1position: contributordoi
Surgery for multiple gastric gastrointestinal stromal tumors and large esophageal diverticulum related to germline mutation of the KIT gene: a case report.
2023cited by 0position: contributordoi
Is simply covering the patient's mouth with a surgical mask during transnasal endoscopy sufficient as an anti-COVID-19 measure?
Clinical Endoscopy 2023cited by 0position: contributordoi
Efficacy and safety of regorafenib in Japanese patients with advanced gastrointestinal stromal tumors.
2022cited by 4position: contributordoi
Real-world data on the efficacy and safety of adjuvant chemotherapy in Japanese patients with a high-risk of gastrointestinal stromal tumor recurrence.
2022cited by 2position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 42 papers (2020–2026)Takuro Saito · The University of Osaka13 papers (2020–2026)Tomoki Makino · Osaka Gakuin University12 papers (2021–2026) · 8 papers (2023–2026)Yukinori Kurokawa · Soka University8 papers (2023–2026) · 6 papers (2023–2026)Hidetoshi Eguchi · Analysis Group (United States)6 papers (2023–2026)Hisashi Wada · The University of Osaka4 papers (2023–2026)Kazuyoshi Yamamoto · Osaka Gakuin University4 papers (2021–2026)Koji Tanaka · Springer Nature2 papers (2023–2025)Shimon Sakaguchi · Cornell University2 papers (2024–2026)Ryugo Teranishi · Children's Hospital of Philadelphia2 papers (2023–2023)Eichi Sato · Tokyo Medical University2 papers (2024–2026)Hiroshi Imamura · Shinshu University2 papers (2025–2026)Tomo Ishida · Ehime University2 papers (2021–2023)Yasuhiro Miyazaki · Osaka General Medical Center2 papers (2021–2021)Masaaki Motoori · Springer Nature2 papers (2021–2023)Yoshiaki Yasumizu · Yale University2 papers (2024–2026)Yohei Nose · Osaka City University2 papers (2023–2026)Toshirou Nishida · National Cancer Centre Japan2 papers (2015–2024)